Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alligator Bioscience Share Issue/Capital Change 2025

Sep 30, 2025

3138_rns_2025-09-30_5d1a714c-2534-4856-bfe0-172f5320fe3b.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

CHANGE IN NUMBER OF SHARES AND VOTES IN ALLIGATOR BIOSCIENCE AB

During September 2025, the number of shares and votes in Alligator Bioscience AB ("Alligator Bioscience") has increased as a result of the exercise of warrants series TO 13, issued in connection with the rights issue of units carried out during December 2024 – February 2025.

As of 30 September 2025, the total number of shares and votes in Alligator Bioscience amounts to 43,813,672, of which all outstanding shares are ordinary shares with one vote each.

For further information, please contact:

Søren Bregenholt, CEO E-mail: [email protected] Phone: +46 (0) 46 540 82 00

This information is information that Alligator Bioscience is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2025-09-30 15:00 CEST.

Attachments

Change in number of shares and votes in Alligator Bioscience AB